XBIRA 500

Xylistin 1 MU, manufactured by Cipla, is a potent prescription antibiotic containing 1 Million IU of Colistimethate Sodium. Presented as a sterile powder for solution, it is specifically indicated for the treatment of severe, acute, or chronic bacterial infections caused by susceptible Gram-negative pathogens, particularly when other first-line therapeutic options are ineffective. This critical medication is versatile in its delivery, formulated strictly for intravenous infusion or inhalation use depending on the clinical target. Because of its targeted potency, administration and precise dosage calculations must always be supervised by qualified healthcare professionals in a monitored clinical setting.